Traditional and Novel Risk Factors of Diabetic Retinopathy and Research Challenges

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|26|3189-3199

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.26, 2013-01, pp. : 3189-3199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of growth factors in the pathogenesis of diabetic retinopathy

By Grant Maria B   Afzal Aqeela   Spoerri Polyxenie   Pan Hao   Shaw Lynn C   Mames Robert N  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1275-1293

Informa Healthcare

Access to resources Recommend Favorite

Non-Traditional Systemic Treatments for Diabetic Retinopathy: An Evidence-Based Review

By  

Current Medicinal Chemistry, Vol. 22, Iss. 21, 2015-01 ,pp. : 2580-2589

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Vitreous Modulators for Pharmacologic Vitreolysis in the Treatment of Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 410-422

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Ischemic Stroke: Overview of Traditional Risk Factors

By  

Current Drug Targets, Vol. 8, Iss. 7, 2007-07 ,pp. : 794-801

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Traditional Risk Factors: Homocysteine and Atherosclerosis

By  

Heart Drug, Vol. 1, Iss. 3, 2001-07 ,pp. : 160-168

Karger

Access to resources Recommend Favorite